These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 395963)

  • 41. Verapamil and the heart: Pharmacological and Therapeutic Considerations.
    DPhil BN
    N Z Med J; 1975 Nov; 82(552):339-43. PubMed ID: 1061888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electrophysiological studies on the effect of cordarone].
    Piwowarska W; Sniezek-Maciejewska M; Szczepkowski J
    Kardiol Pol; 1984; 27(3):181-9. PubMed ID: 6737834
    [No Abstract]   [Full Text] [Related]  

  • 43. [Calcium inhibitors in the early rehabilitation of patients with myocardial infarct].
    Rossi P; Giordano A; Tamiz A; Schiavo B; Minuco G
    Boll Soc Ital Cardiol; 1978; (1 Suppl):142-55. PubMed ID: 757676
    [No Abstract]   [Full Text] [Related]  

  • 44. [Electrophysiological mechanisms of the anti-arrhythmia action of ethacizin].
    Malakhov VI; Golitsyn SP; Sokolov SF; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):112-6. PubMed ID: 3541960
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effects of calcium antagonists on isolated myocardial tissue and their molecular mechanism of action].
    Bayer R; Kaufmann R; Rodenkirchen R; Mannhold R
    Herz; 1982 Aug; 7(4):203-10. PubMed ID: 6127299
    [No Abstract]   [Full Text] [Related]  

  • 46. Calcium antagonists and cardiac dysrhythmias.
    Anderson GJ; Reiser J
    Am Fam Physician; 1981 Mar; 23(3):214-5. PubMed ID: 7468411
    [No Abstract]   [Full Text] [Related]  

  • 47. The cardiac electrophysiological effects of nifedipine.
    Padeletti L; Franchi F; Brat A; Dabizzi RP; Michelucci A
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):290-3. PubMed ID: 489193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proceedings: Ca-dependence of supraventricular pacemaker activity and its responsiveness to Ca-antagonistic compounds (verapamil, D 600, nifedipine).
    Haastert HP; Fleckenstein A
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R39. PubMed ID: 1143433
    [No Abstract]   [Full Text] [Related]  

  • 49. [Calcium antagonists. Properties and current indications].
    Amoroso A; Lanciotti G; Mammarella A
    Recenti Prog Med; 1984 Apr; 75(4):353-60. PubMed ID: 6374795
    [No Abstract]   [Full Text] [Related]  

  • 50. Modulation of the effects of postganglionic vagal stimulation in the sinus and atrioventricular nodes by cardioactive agents and electrolytes.
    Dreifus LS; Mazgalev T; Miyagawa A; Michelson EL
    Prog Clin Biol Res; 1988; 275():207-23. PubMed ID: 3174672
    [No Abstract]   [Full Text] [Related]  

  • 51. Differential effects of organic slow inward current inhibitors, verapamil and nifedipine, on rate of atrioventricular rhythm and supraventricular tachycardia in the canine isolated, blood-perfused AV node preparation.
    Motomura S; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jan; 315(3):241-8. PubMed ID: 7219573
    [No Abstract]   [Full Text] [Related]  

  • 52. [Action of the calciumantagonistic compound gallopamile on sinus node, atrioventricular and intraventricular conduction (author's transl)].
    Beck OA; Witt E; Lehmann HU; Hochrein H
    Z Kardiol; 1978 Aug; 67(8):522-6. PubMed ID: 695803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of dihydropyridine calcium-antagonists on intracellular action potentials of rabbit sinus node, atrium and atrioventricular node. Comparison of felodipine with nifedipine.
    Beyer T; Brachmann J; Kübler W
    Arzneimittelforschung; 1994 Jun; 44(6):707-11. PubMed ID: 8053968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].
    Grosu AA
    Kardiologiia; 1985 May; 25(5):114-8. PubMed ID: 3894756
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcium-antagonistic and anti-arrhythmic effects of nifedipine on the isolated rat atrium.
    Refsum H
    Acta Pharmacol Toxicol (Copenh); 1975 Nov; 37(5):377-86. PubMed ID: 1242864
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of calcium-entry antagonists in hypertension.
    Krebs R; Graefe KH; Ziegler R
    Clin Exp Hypertens A; 1982; 4(1-2):271-84. PubMed ID: 7074989
    [No Abstract]   [Full Text] [Related]  

  • 58. [Acute effects of nifedipine and verapamil on arterial pressure, at rest and during and after exercise in hypertensive patients].
    Novo S; Riolo F; Pinto A; Davì G; Botindari C
    Boll Soc Ital Cardiol; 1980; 25(2):157-63. PubMed ID: 7236440
    [No Abstract]   [Full Text] [Related]  

  • 59. [Calcium inhibitors. Current indications in cardiology].
    Lancelin B; Blanchard D; Aziza JP; Guermonprez JL; Maurice P
    Rev Prat; 1980 Feb; 30(7):363-8. PubMed ID: 7361048
    [No Abstract]   [Full Text] [Related]  

  • 60. The blockade of Vmax of the atrioventricular action potential produced by the slow channel inhibitors verapamil and nifedipine.
    Kohlhardt M; Haap K
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):178-85. PubMed ID: 6264331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.